Drugs / PNAT
PNAT
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02873416 | Aug 2016 → Mar 2018 | lung cancer | Ningbo Cancer Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT02862587 | Aug 2016 → Mar 2018 | lung cancer | Shanghai International Medical Center | Unknown | No outcome recorded |
| Phase 1/2 | NCT02873520 | Aug 2016 → Mar 2018 | gastric cancer | Ningbo Cancer Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT02632019 | Sep 2015 → Mar 2017 | biliary tract cancer | Second Military Medical University | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PNAT | “Precision Cell suspension (1-6×109 PNAT + physiological saline + 0.25% human bloodalbumin) 300ml for each infusion, IV (in the vein) for each infusion, 3 cycles, each cycle...” NCT02873416 ↗1“PNAT cell suspension (1-6×109 PNAT + physiological saline + 0.25% human serum albumin) 300ml for each infusion, IV (in the vein) for each infusion, 3 cycles, each cycle...” NCT02632019 ↗ |
| Known as | PNAT/PMAT | “PNAT/PMAT cell suspension (1-6×109 PNAT + physiological saline + 0.25% human bloodalbumin) 300ml for each infusion, IV (in the vein) for each infusion” NCT02862587 ↗ |
| Known as | PNAT/PMAT cell suspension | “PNAT/PMAT cell suspension (1-6×109 PNAT + physiological saline + 0.25% human bloodalbumin) 300ml for each infusion” NCT02873520 ↗ |
| Modality | Cell therapy | “PNAT cell suspension (1-6×109 PNAT + physiological saline + 0.25% human serum albumin)” NCT02632019 ↗ |
| Route | Intravenous | “IV (in the vein) for each infusion” NCT02632019 ↗ |